Professional Documents
Culture Documents
Workbook
questions
110
1114
1518
16, 1922
2324
2528
2830
3133
3435
____________________________________________________________________________________________________________________
Copyright 2013 by MedIQ Learning, LLC All rights reserved v1.2
This copy belong to the User: 61838
This copy is downloaded on: 5/14/2013 7:46 PM
Questions
ANATOMY
1.
Anisocytosis _______________________________________________________________
B.
Leukocytosis _______________________________________________________________
C.
Poikilocytosis _______________________________________________________________
D.
Thrombocytopenia __________________________________________________________
2.
3.
4.
5.
CD14 is a cell surface marker for which cell type? (p. 345) _______________________________
6.
7.
copy
downloaded
on: 5/14/2013
7:46 PM
List the types of white bloodThis
cells
inisorder
of decreasing
prevalence.
(pp. 345-346) ____________
______________________________________________________________________________
8.
B lymphocytes are produced in the _______________ (bone marrow/thymus) and mature in the
_______________ (bone marrow/thymus). T lymphocytes are produced in the _______________
(bone marrow/thymus) and mature in the _______________ (bone marrow/thymus). (pp. 346-347)
9.
What molecules are in the granules of mast cells? (p. 346) ________________________________
10.
What type of cell has an off-center nucleus, abundant RER, and a clock-face chromatin
distribution? (p. 346) ______________________________________________________________
PHYSIOLOGY
11.
____________________________________________________________________________________________________________________
Copyright 2013 by MedIQ Learning, LLC All rights reserved v1.2
This copy belong to the User: 61838
This copy is downloaded on: 5/14/2013 7:46 PM
12.
In the chart, check which coagulation factors are in the intrinsic vs. the extrinsic coagulation
pathways. (p. 348)
Factor
Extrinsic Pathway
Intrinsic Pathway
Both Pathways
I
II
V
VII
VIII
IX
X
XI
XII
13.
Which factors are vitamin K dependent? How does warfarin inhibit the activation of these factors?
(p. 348) ________________________________________________________________________
14.
Describe the four steps of primary hemostasis and platelet plug formation. (p. 349) ____________
______________________________________________________________________________
PATHOLOGY
15.
Identify each cell type and its associated pathology. (pp. 350-351)
A.
16.
B.
C.
D.
E.
F.
A. _______________________________
D. ______________________________
B. _______________________________
E. ______________________________
C. _______________________________
F. ______________________________
Indicate whether the lab findings in the chart are elevated, decreased, or normal. (pp. 352-355)
Lab Value
Anemia of
Chronic
Disease
Hemochromatosis
Iron
Deficiency
Pregnancy/
OCPs
Thalassemia
Ferritin
Serum iron
Transferrin
% Transferrin
____________________________________________________________________________________________________________________
Copyright 2013 by MedIQ Learning, LLC All rights reserved v1.2
This copy belong to the User: 61838
This copy is downloaded on: 5/14/2013 7:46 PM
17.
In -thalassemia, what is the condition called when all four -globin genes are deleted? When
three are deleted? When one or two are deleted? (p. 352) ________________________________
______________________________________________________________________________
18.
What are the major history and physical exam findings of lead poisoning? (p. 353) _____________
______________________________________________________________________________
19.
What clinical manifestations do folate deficiency and vitamin B12 deficiency have in common? What
sets them apart? (p. 354) __________________________________________________________
20.
21.
Match the intrinsic hemolytic normocytic anemia with its characteristic. (p. 356)
_____ A. G6PD deficiency
_____ B. HbC defect
_____ C. Hereditary spherocytosis
_____ D. Paroxysmal nocturnal hemoglobinuria
_____ E. Pyruvate kinase deficiency
_____ F. Sickle cell anemia
22.
1.
2.
3.
4.
5.
6.
Which autoimmune hemolytic anemias are associated with warm agglutinins? With cold
agglutinins? (p. 357) ______________________________________________________________
______________________________________________________________________________
23.
24.
Indicate whether the lab findings in the chart are elevated, decreased, or normal. (pp. 359-360)
Disorder
Platelet
Count
Bleeding
Time
PT
PPT
DIC
Glanzmanns thromboasthenia
Hemophilia
ITP/TTP
Vitamin K deficiency
von Willebrands disease
25.
____________________________________________________________________________________________________________________
Copyright 2013 by MedIQ Learning, LLC All rights reserved v1.2
This copy belong to the User: 61838
This copy is downloaded on: 5/14/2013 7:46 PM
26.
Which type of Hodgkins lymphoma is more common in women? (p. 362) ____________________
27.
What will serum protein electrophoresis reveal in a patient with multiple myeloma? What will be
seen in the urine? (p. 363) _________________________________________________________
28.
Match the disease with the genetic translocation most closely associated with it. (pp. 362-365)
_____ A. Burkitts lymphoma
_____ B. Chronic myelogenous leukemia
_____ C. Ewings sarcoma
_____ D. Follicular lymphoma
_____ E. M3 type of AML
_____ F. Mantle cell lymphoma
29.
1.
2.
3.
4.
5.
6.
t(8;14)
t(9;22)
t(11;14)
t(11;22)
t(14;18)
t(15;17)
What are the four major groups of leukemias? Which type is at risk of DIC upon initiation of
treatment and why? (pp.364-365)___________________________________________________
_______________________________________________________________________________
30.
Indicate whether the lab findings in the chart are elevated, decreased, or normal. (p. 366)
Chronic
Myeloproliferative
Disorder
Platelets
RBCs
WBCs
CML
Essential
thrombocytosisThis copy belong to the User: 61838
This copy is downloaded on: 5/14/2013 7:46 PM
Myelofibrosis
Polycythemia vera
PHARMACOLOGY
31.
Indicate how the drugs in the chart affect the lab findings. (pp. 367-368)
Drug
Bleeding
Time
Platelet
Count
PT
PTT
Aspirin
Clopidogrel/abciximab
Heparin
Warfarin
32.
What is the mechanism of action of heparin? How is overdose treated? (p. 368) _______________
______________________________________________________________________________
33.
What is the mechanism of action of warfarin? How is overdose treated? (p. 368) ______________
______________________________________________________________________________
____________________________________________________________________________________________________________________
Copyright 2013 by MedIQ Learning, LLC All rights reserved v1.2
This copy belong to the User: 61838
This copy is downloaded on: 5/14/2013 7:46 PM
34.
35.
1.
2.
3.
4.
5.
6.
7.
8.
9.
10.
Match the patient with the drug he or she is most likely taking. (pp. 371-372)
_____ A. Patient preparing for bone marrow transplantation has
1. Bleomycin
PFTs consistent with restrictive lung disease
2. Busulfan
_____ B. Patient with colon cancer has myelosuppression
3. Cyclophosphamide
not reversible with leucovorin
4. Doxorubicin
_____ C. Patient with non-Hodgkins lymphoma is having
5. 5-Fluorouracil
hemorrhagic cystitis
6. Methotrexate
_____ D. Patient with leukemia is having myelosuppression
reversible with leucovorin
_____ E. Patient with solid tumor is having dilated cardiomyopathy
_____ F. Patient with testicular cancer has PFTs consistent with restrictive lung disease
This copy belong to the User: 61838
This copy is downloaded on: 5/14/2013 7:46 PM
____________________________________________________________________________________________________________________
Copyright 2013 by MedIQ Learning, LLC All rights reserved v1.2
This copy belong to the User: 61838
This copy is downloaded on: 5/14/2013 7:46 PM
Answers
ANATOMY
1.
A.
B.
C.
D.
2.
3.
4.
4,00010,000/mm .
5.
Macrophages.
6.
7.
8.
Thismarrow;
copy belong
to the User: 61838
Bone marrow; bone marrow; bone
thymus.
9.
10.
Plasma cell.
PHYSIOLOGY
11.
To prevent the development of anti-Rh IgG, which can cause erythroblastosis fetalis in a
subsequent fetus.
12.
Factor
Extrinsic Pathway
Intrinsic Pathway
Both Pathways
II
VII
VIII
IX
X
XI
XII
____________________________________________________________________________________________________________________
Copyright 2013 by MedIQ Learning, LLC All rights reserved v1.2
This copy belong to the User: 61838
This copy is downloaded on: 5/14/2013 7:46 PM
13.
Factors II, VII, IX, X, and proteins C and S. Warfarin inhibits the enzyme epoxide reductase, which
is necessary to convert vitamin K to its reduced form so that it can go on to activate these factors.
14.
Injury: Endothelial damage prompts vWF binding to exposed collagen. Adhesion: Platelets bind
2+
vWF and release ADP/Ca . Activation: GpIIb/IIIa is expressed. Aggregation: Fibrinogen binds
GpIIb/IIIa and links platelets.
PATHOLOGY
15.
16.
Lab Value
Anemia of
Chronic
Disease
Hemochromatosis
Iron
Deficiency
Pregnancy/
OCPs
Thalassemia
Ferritin
normal
normal
Serum iron
normal
normal
Transferrin
normal
normal
% Transferrin
normal to
17.
Four deletions: Hb Barts; three deletions: HbH disease; one or two deletions: asymptomatic.
18.
History reveals abdominal colic and confusion. Physical exam shows wrist and foot drop and
Burtons lines on gingiva.
19.
Both folic acid and vitamin B12 deficiency can cause megaloblastic anemia. Only vitamin B12
deficiency, however, is associated with neurologic symptoms, such as peripheral neuropathy,
posterior column degeneration, spasticity, and dementia.
20.
Idiopathic, radiation and drug exposure, viral infection, and Fanconis anemia.
21.
22.
Warm agglutinins (IgG): SLE, chronic lymphocytic leukemia, and certain drug reactions.
Cold agglutinins (IgM): chronic lymphocytic leukemia, Mycoplasma pneumoniae infection, and
infectious mononucleosis.
23.
____________________________________________________________________________________________________________________
Copyright 2013 by MedIQ Learning, LLC All rights reserved v1.2
This copy belong to the User: 61838
This copy is downloaded on: 5/14/2013 7:46 PM
24.
Platelet
Count
Disorder
Bleeding
Time
PT
PPT
Glanzmanns thromboasthenia
normal
normal
normal
Hemophilia
normal
normal
normal
normal
normal
Vitamin K deficiency
normal
normal
normal
normal
DIC
ITP/TTP
25.
26.
Nodular sclerosing.
27.
An M-spike, representing a monoclonal antibody; IgG light chains (Bence Jones proteins).
28.
29.
AML, ALL, CML, and CLL. AML can be associated with DIC upon initiation of treatment because
the leukemia cells contain Auer rods composed of the enzyme peroxidase, which is released into
the bloodstream when treatment causes cells to lyse.
This copy belong to the User: 61838
This copy is downloaded on: 5/14/2013 7:46 PM
30.
Chronic
Myeloproliferative
Disorder
Platelets
CML
Essential
thrombocytosis
Myelofibrosis
RBCs
WBCs
variable
variable
Polycythemia vera
PHARMACOLOGY
31.
Drug
Bleeding
Time
Platelet
Count
PT
PTT
Aspirin
normal
normal
normal
Clopidogrel/abciximab
normal
normal
normal
Heparin
normal
normal
Warfarin
normal
normal
____________________________________________________________________________________________________________________
Copyright 2013 by MedIQ Learning, LLC All rights reserved v1.2
This copy belong to the User: 61838
This copy is downloaded on: 5/14/2013 7:46 PM
32.
Heparin activates antithrombin, decreasing thrombin and Xa. Treat heparin overdose with
protamine sulfate.
33.
Warfarin interferes with normal synthesis and -carboxylation of vitamin K-dependent clotting
factors. Treat warfarin overdose with intravenous vitamin K and fresh frozen plasma.
34.
A-5, B-1, C-9, D-8, E-3, F-2, G-4, H-7, I-6, J-10.
35.
____________________________________________________________________________________________________________________
Copyright 2013 by MedIQ Learning, LLC All rights reserved v1.2
This copy belong to the User: 61838
This copy is downloaded on: 5/14/2013 7:46 PM